Taysha Gene Therapies Inc (TSHA)
SG&A Expenses
$38.94M
TTM · Period ending: · USD
TSHA SG&A Expenses
Latest reported$38.94Mperiod ending
Latest reported$38.94Mperiod ending
TSHA TTM SG&A Expenses ($5.13M → $38.94M)
TTM SG&A Expenses
High-resolution chart · PNG
TSHA sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 38,935,000 | |
| 35,387,000 | |
| 33,868,000 | |
| 31,664,000 | |
| 31,287,000 | |
| 30,027,000 | |
| 28,953,000 | |
| 29,043,000 | |
| 29,398,999 | |
| 27,345,999 | |
| 28,381,998 | |
| 27,324,998 | |
| 27,749,999 | |
| 32,331,999 | |
| 35,681,000 | |
| 41,825,000 | |
| 44,295,000 | |
| 44,557,000 | |
| 41,324,000 | |
| 35,625,000 | |
| 28,456,000 | |
| 19,275,000 | |
| 11,109,000 | |
| 5,130,000 |